Relapsed/refractory Diffuse Large B-Cell Lymphoma is related to burkitt lymphoma and lymphoma, hodgkin, classic. An important gene associated with Relapsed/refractory Diffuse Large B-Cell Lymphoma is CD19 (CD19 Molecule), and among its related pathways/superpathways are ERK Signaling and GPCR Pathway. The drugs Gemcitabine and Rituximab have been mentioned in the context of this disorder. Affiliated tissues include t cells and nk cells, and related phenotypes are Reduced mammosphere formation and cellular